Trials and Tribulations of EGFR and MET Inhibitor Combination Therapy in NSCLC

Grants

Funding Acknowledgements

Dr. Solomon reports personal fees from Pfizer, Novartis, Roche Genentech, and AstraZeneca during the conduct of the study and personal fees from Bristol-Myers Squibb and Merck outside the submitted work.